To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden

Clinical trial NCT00991419 · COMPLETED

Trial details

NCT number: NCT00991419
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2010-02-01
Primary completion: 2011-08-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.